ARF1 and colorectal carcinoma: The modulation of lipid metabolism through ADP ribosylation factor 1 (ARF1) curtails the release of damage‐associated molecular patterns (DAMPs), which compromise antitumor immune surveillance by suppressing T‐cell infiltration and activation in CRC.119